|
1. |
Cardiomyocyte Cultures With Controlled Macroscopic AnisotropyA Model for Functional Electrophysiological Studies of Cardiac Muscle |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 45-54
N.,
Bursac K.,
Parker S.,
Iravanian L.,
Preview
|
PDF (1074KB)
|
|
摘要:
Abstract—Structural and functional cardiac anisotropy varies with the development, location, and pathophysiology in the heart. The goal of this study was to design a cell culture model system in which the degree, change in fiber direction, and discontinuity of anisotropy can be controlled over centimeter-size length scales. Neonatal rat ventricular myocytes were cultured on fibronectin on 20-mm diameter circular cover slips. Structure-function relationships were assessed using immunostaining and optical mapping. Cell culture on microabraded cover slips yielded cell elongation and coalignment in the direction of abrasion, and uniform, macroscopically continuous, elliptical propagation with point stimulation. Coarser microabrasion (wider and deeper abrasion grooves) increased longitudinal (23.5 to 37.2 cm/s;r=0.66) and decreased transverse conduction velocity (18.1 to 9.2 cm/s;r=−0.84), which resulted in increased longitudinal-to-transverse velocity anisotropy ratios (1.3 to 3.7, n=61). A thin transition zone between adjacent uniformly anisotropic areas with 45° or 90° difference in fiber orientation acted as a secondary source during 2× threshold field stimulus. Cell culture on cover slips micropatterned with 12- or 25-&mgr;m wide fibronectin lines and previously coated with decreasing concentrations of background fibronectin yielded transition from continuous to discontinuous anisotropic architecture with longitudinally oriented intercellular clefts, decreased transverse velocity (16.9 to 2.6 cm/s;r=−0.95), increased velocity anisotropy ratios (1.6 to 5.6, n=70), and decreased longitudinal velocity (36.4 to 14.6 cm/s;r=−0.85) for anisotropy ratios >3.5. Cultures of cardiac myocytes with controlled degree, uniformity and continuity of structural, and functional anisotropy may enable systematic 2-dimensional in vitro studies of macroscopic structure-related mechanisms of reentrant arrhythmias. The full text of this article is available at http://www.circresaha.org.
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
2. |
Nonendothelial Source of Nitric Oxide in Arterioles But Not in VenulesAlternative Source Revealed In Vivo by Diaminofluorescein Microfluorography |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 55-64
Satoshi,
Kashiwagi Mayumi,
Kajimura Yasunori,
Yoshimura Makoto,
Preview
|
PDF (873KB)
|
|
摘要:
Abstract—This study aimed to examine topographic distribution of microvascular NO generation in vivo. To this end, nitrosonium ion (NO+)–sensitive diaminofluorescein diacetate was superfused continuously on the rat mesentery and the fluorescence was visualized in the microvessels through laser confocal microfluorography. Two major sites exhibited a time-dependent elevation of the fluorescence: microvascular endothelia and mast cells. As judged by the fluorescence sensitivity to local application of different inhibitors of NO synthase (NOS), NO availability in arteriolar endothelium and mast cells appeared to be maintained mainly by NOS1, whereas that in venular endothelium greatly depends on NOS3. In venules, the magnitude of inhibitory responses elicited by the inhibitors was positively correlated with the density of leukocyte adhesion. NOS inhibitors significantly reduced, but did not eliminate, the NO+-associated fluorescence in arterioles, capillaries, and venules, suggesting alternative sources of NO in circulation for these microvessels. Immunohistochemistry for NOS isozymes revealed that NOS1 occurred not only in nerve fibers innervated to arterioles but also abundantly in mast cells. Laser flow cytometry of peritoneal cells in vitro revealed abundant expression of NOS1 in mast cells. Interestingly, NOS3 occurred in endothelia of capillaries and venules but not in those of distal arterioles with comparable diameters. These results suggest that the arterioles receive NO from nonendothelial origins involving NOS1 present in nerve terminals and mast cells, whereas venules depend on the endothelial NOS as a major source. Furthermore, nonenzymatic sources of NO from circulating reservoirs constitute a notable fraction throughout different classes of microvessels. The full text of this article is available at http://www.circresaha.org.
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
3. |
Correction |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 65-65
&NA;,
Preview
|
PDF (4KB)
|
|
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
4. |
Acknowledgment to Reviewers |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 1079-1081
Preview
|
|
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
5. |
Bioactive Peptide Signaling Within the Myocardial Interstitium and the Matrix Metalloproteinases |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 1082-1084
Francis,
Preview
|
PDF (461KB)
|
|
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
6. |
Alive and KickingEndothelium at the Geographic Nexus of Vascular Rejection |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 1085-1088
Sean,
Mazer David,
Preview
|
PDF (106KB)
|
|
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
7. |
Neuronal Nitric Oxide Synthase Gene Transfer Promotes Cardiac Vagal Gain of Function |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 1089-1091
R.,
Mohan D.,
Heaton E.,
Danson S.,
Krishnan S.,
Cai K.,
Channon D.,
Preview
|
PDF (252KB)
|
|
摘要:
Nitric oxide (NO) generated from neuronal nitric oxide synthase (NOS-1) in intrinsic cardiac ganglia has been implicated in parasympathetic-induced bradycardia. We provide direct evidence that NOS-1 acts in a site-specific manner to promote cardiac vagal neurotransmission and bradycardia. NOS-1 gene transfer to the guinea pig right atrium increased protein expression and NOS-1 immunolocalization in cholinergic ganglia. It also increased the release of acetylcholine and enhanced the heart rate (HR) response to vagal nerve stimulation (VNS) in vitro and in vivo. NOS inhibition normalized the HR response to VNS in the NOS-1–treated group compared with the control groups (enhanced green fluorescent protein and sham) in vitro. In contrast, an acetylcholine analogue reduced HR to the same extent in all groups before and during NOS inhibition. These results demonstrate that NOS-1–derived NO acts presynaptically to facilitate vagally induced bradycardia and that upregulation of NOS-1 via gene transfer may provide a novel method for increasing cardiac vagal function.
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
8. |
Stem Cells for Myocardial Regeneration |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 1092-1102
Donald,
Orlic Jonathan,
Hill Andrew,
Preview
|
PDF (559KB)
|
|
摘要:
Abstract—Stem cells are being investigated for their potential use in regenerative medicine. A series of remarkable studies suggested that adult stem cells undergo novel patterns of development by a process referred to as transdifferentiation or plasticity. These observations fueled an exciting period of discovery and high expectations followed by controversy that emerged from data suggesting cell-cell fusion as an alternate interpretation for transdifferentiation. However, data supporting stem cell plasticity are extensive and cannot be easily dismissed. Myocardial regeneration is perhaps the most widely studied and debated example of stem cell plasticity. Early reports from animal and clinical investigations disagree on the extent of myocardial renewal in adults, but evidence indicates that cardiomyocytes are generated in what was previously considered a postmitotic organ. On the basis of postmortem microscopic analysis, it is proposed that renewal is achieved by stem cells that infiltrate normal and infarcted myocardium. To further understand the role of stem cells in regeneration, it is incumbent on us to develop instrumentation and technologies to monitor myocardial repair over time in large animal models. This may be achieved by tracking labeled stem cells as they migrate into myocardial infarctions. In addition, we must begin to identify the environmental cues that are needed for stem cell trafficking and we must define the genetic and cellular mechanisms that initiate transdifferentiation. Only then will we be able to regulate this process and begin to realize the full potential of stem cells in regenerative medicine.
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
9. |
Gene Expression in Fibroblasts and FibrosisInvolvement in Cardiac Hypertrophy |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 1103-1113
Ichiro,
Manabe Takayuki,
Shindo Ryozo,
Preview
|
PDF (148KB)
|
|
摘要:
Abstract—Structural remodeling of the ventricular wall is a key determinant of clinical outcome in heart disease. Such remodeling involves the production and destruction of extracellular matrix proteins, cell proliferation and migration, and apoptotic and necrotic cell death. Cardiac fibroblasts are crucially involved in these processes, producing growth factors and cytokines that act as autocrine and paracrine factors, as well as extracellular matrix proteins and proteinases. Recent studies have shown that the interactions between cardiac fibroblasts and cardiomyocytes are essential for the progression of cardiac remodeling. This review addresses the functional role played by cardiac fibroblasts and the molecular mechanisms that govern their activity during cardiac hypertrophy and remodeling. A particular focus is the recent progress toward our understanding of the transcriptional regulatory mechanisms involved.
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
10. |
Brugada SyndromeA Decade of Progress |
|
Circulation Research: Journal of the American Heart Association,
Volume 91,
Issue 12,
2002,
Page 1114-1118
C.,
Antzelevitch P.,
Brugada J.,
Brugada R.,
Brugada W.,
Shimizu I.,
Gussak A.,
Preview
|
PDF (56KB)
|
|
摘要:
Abstract—The Brugada syndrome has gained wide recognition throughout the world and today is believed to be responsible for 4% to 12% of all sudden deaths and ≈20% of deaths in patients with structurally normal hearts. The incidence of the disease is on the order of 5 per 10 000 inhabitants and, apart from accidents, is the leading cause of death of men under the age of 50 in regions of the world where the inherited syndrome is endemic. This minireview briefly summarizes the progress made over the past decade in our understanding of the clinical, genetic, cellular, ionic, and molecular aspects of this disease.
ISSN:0009-7330
出版商:OVID
年代:2002
数据来源: OVID
|
|